Measurement of cytokines, bloodflow and erythema after shear- force application of the skin in patients with Diabetes Mellitus - The effect of shear- force in patients with Diabetes Mellitus

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 40 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•- Healthy volunteers
•- age 40 years or older and 75 years and younger;Group B;
•- patients with Diabetes Mellitus type 2 (DM) without neuropathy
•- age 40 years or older and 75 years and younger
•- Valk score < 4;Group C:
•- Patients with DM type 2 with neuropathy
•- age 40 years or older and 75 years and younger
•- Valk score > 4;Group D
•- Patients with (pre)- existing Charcot Ostheoarhtropathy
•- age 40 years or older and 75 years and younger
•- Valk score > 4;In all patients we are going to determine the Valk score to measure the amount of neuropathy in patients. The Valk score is going to be determined by someone of the research committee, or under the supervision of someone of the research committee.

•- Trauma fore arms
•- Skin diseases (psoriasis, eczema)
•- NSAID use in last seven days
•- Corticosteroïds
•- Auto- iimune diseases
•- Muscular dystrophy
•- Malignancy
•- Participant is unable to give informed consent
•- No peripheral pulsations (a. radialis, a. dorsalis pedis, a. tibialis anterior)
•- Hab1c percentage last 3 months > 11%

发起方

Medisch Universitair Ziekenhuis Maastricht